Best Leukemia chemotherapy hematologist-oncologists: TOP 92 doctors

• Dr. Mustafa Özdoğan specializes in advanced leukemia chemotherapy techniques.
• Expertise in targeted therapy, immunotherapy, and hematopoietic stem cell transplantation.
• International training includes the U.S., Germany, and the United Kingdom.
• Holds Board Certification in Medical Oncology, ensuring specialized leukemia care.
• Member of the American Society of Clinical Oncology (ASCO) with a focus on leukemia.
• Offers online consultations for international and remote leukemia patients.
• Fluent in English and Turkish, facilitating care for diverse patient backgrounds.

• Dr. Serdar Turhal specializes in leukemia chemotherapy at Anadolu Medical Center.
• Utilizes innovative methods like targeted therapy, immunotherapy, and stem cell transplant.
• International training in the USA at Yale University and Mount Sinai Medical Center.
• Member of ASCO, ESMO, EORTC, BUOn, and TOD with a focus on oncology.
• Offers online consultations for international patients with leukemia.
• Languages spoken: English and Turkish.
• Over 20 years of experience in medical oncology.

Dr. Ahmet Belici is an experienced medical oncologist with 20+ years of experience specializing in sarcoma and lung cancer treatments.

Dr. Ofer Merimsly is the best sarcoma, lymphoma, and lung cancer doctor within Israel and in the world. Also specializes in Whipple surgery treatment for patients with pancreatic cancer. Head of the National Center for sarcomas of bone and soft tissues of the Tel Aviv Medical Center Sourasky (Ichilov).

Specialty:

• Treatment of all types of lung cancer and thoracic organs
• Treatment of all types of sarcomas of bone and soft tissue
• Treatment stromal tumors of the gastrointestinal tract

Education and specialization:

• Higher medical education, graduated the Medical Faculty of the Hebrew University of Jerusalem, Israel
• Residency in General Oncology and Radiotherapy
• Training in the field of radiotherapy and brachytherapy at New York Hospital, USA
• Special refresher course for the treatment of tumors of the skeleton and soft tissues, Paris. France

Membership:

• President of the Society of oncologists and radiotherapists Israel
• The American Scientific Cancer Society
• European scientific medical organization
• European Society of Oncology of the musculoskeletal system
• International Society for the treatment of tumors of the connective tissue

Dr. K.K. Iswaran is a highly experienced Obstetrician and Gynaecologist with 25+ years of experience in Obstetrics & Gynaecology Reproduction Medicine, IUI - Intrauterine Insemination, Ovulation Induction Procedure, Ovarian Drilling (Multiperforation), Urethral Valves, and more. He holds a Fellowship, Diploma, and MBBS from the Ronald O Perelman and Claudia Cohen Centre, Ireland, and the University of Mysore, India respectively.

Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.

• Dr. Boris Pfaffenbach specializes in Leukemia chemotherapy.
• Performs chemotherapy using methods like intravenous, oral, and intrathecal administration.
• Innovative techniques include targeted therapy, immunotherapy, and CAR T-cell therapy.
• International practice in Germany with training in advanced oncology treatments.
• Board-certified in internal medicine and gastroenterology with a focus on oncology.
• Member of the German Society of Gastroenterology and European Society of Gastroenterology.
• Offers online consultations for Leukemia patients requiring chemotherapy.
• Fluent in German and English, providing care to international patients.

• Dr. Elke Jaeger specializes in leukemia chemotherapy using targeted therapy and immunotherapy.
• Expert in innovative leukemia treatments: CAR T-cell therapy, stem cell transplant, precision medicine.
• International practice includes training and collaboration with oncology centers in Europe and the USA.
• Recognized as a top oncologist in Germany by Focus rating for her expertise.
• Holds key certifications in oncology and hematology, ensuring advanced treatment knowledge.
• Active member of professional oncology and hematology societies, contributing to her field's growth.
• Offers online consultations for leukemia patients, providing global access to her expertise.
• Proficient in multiple languages for international patient communication, including English and German.

Areas of Interest

2. Leukemia
3. Lymphoma
4. Multiple myeloma
5. Thalassemia
6. Bone m diseases
7. Plasmapheresis

Education
2005 Graduated from Hacettepe University, Faculty of Medicine
2010 Hacettepe University, Faculty of Medicine Internal Medicine Specialist
2014 Ankara University, Faculty of Medicine Hematology Specialist

Experience
October 2010 - December 2010 Internal Medicine Specialist at Ankara Oncology Hospital
December 2010 - April 2011 Hematology Sub-branch Assistant at Ankara Oncology Hospital
September 2014 - May 2016 Hematology Specialist at Kütahya Dumlupınar University Evliya Çelebi Training and Research Hospital
May 2016 - March 2018 Ufuk University, Faculty of Medicine, Hematology Department Faculty Member
March 2018 - October 2018 Hitit University, Faculty of Medicine, Hematology Department Faculty Member
November 2018 - January 2019 Medical Park Bahçelievler Hematology and Bone Marrow Transplantation Unit physician
February 2019 - June 2022 Present Bayındır Söğütözü Hospital Hematology and Cell Transplantation Unit, Assistant Physician in Charge
June 2022 - July 2022 Afyonkarahisar Health Sciences University, Head of Hematology Department

Qualification Certificates
Internal Medicine Board Qualification Certificate, 2009
Hematology Board Qualification Certificate, 2014
English Proficiency 2017/7 e-YDS Score: 71.25
Internal Medicine Specialization Thesis Addition of 9-Week Trastuzumab to Adjuvant Treatment in Both Positive Breast Cancer Patients Retrospective Analysis

Education Abroad
Between October and December 2007 (3 months) Intensive Care Education at University of Florida, United States
Between December 2013 and January 2014 (2 months) Flow Cytometry Education at Salamanca University, Spain

Courses, Awards, and Certificates
1 Year of Work Certificate in Bone Marrow Transplantation, 2017
Blood Banking and Transfusion Medicine Certificate 2017
“Physician of the Year” Award in Kütahya, 2014
Laboratory GMP, GLP, ISO /IEC 17025: 2012 Certificates, 2014
Good Clinical Practices Certificate, 2013
Şeref Zileli Successful Assistant of the Year Award, 2009
RIA Certificate, 2005

Research and Publications

Patent
1. Half antibody with the fc portion removed (fab) for medical use. Inventor: Mehmet Özen. No:2016/0910. Patent under review.

Scientific Studies
A. Publications in International Journals under SCI Expanded


 Turkish book section

1. Ozen M, Konuk N. Immune thrombocytopenic purpura. Turkoz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.8-12.

2. Özen M, Ural AU. Hematological diseases and mesenchymal stem cell applications. Türköz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Turkey Clinics; 2021. p.91-4.

3. Ozen M. Hematopoiesis and Hematopoietic Growth Factors. MediHealth & Hippocrates INTERNAL DISEASES with Current Guidelines 2022. p1607-10

• Dr. Axel Stang specializes in targeted leukemia chemotherapy.
• Uses methods like immunotherapy, targeted drugs, and transplants.
• Innovative techniques include CAR T-cell therapy, tyrosine kinase inhibitors, and monoclonal antibodies.
• International practice in Germany; educated in molecular genetics and oncology.
• Member of German Society of Hematology and Oncology (DGHO).
• Offers remote consultations for leukemia chemotherapy patients.
• Languages spoken: English and German.

• Dr. Jaume Mora Graupera specializes in pediatric leukemia chemotherapy.
• Utilizes precision medicine approaches, targeted therapies, and hematopoietic stem cell transplantation.
• Trained in pediatric hematology oncology at Weill Cornell and Memorial Sloan Kettering, USA.
• Expert in innovative leukemia treatments: CAR T-cell therapy, tyrosine kinase inhibitors, and immunotherapy.
• Professional memberships include the International Society of Pediatric Oncology and the American Society of Clinical Oncology.
• Offers remote consultations for international patients undergoing leukemia chemotherapy.
• Languages spoken: English and Spanish, facilitating diverse patient communication.

• Dr. Susana Rives Sola specializes in pediatric leukemia chemotherapy.
• Utilizes cutting-edge treatments: CAR-T therapy, precision medicine, and targeted therapy.
• Trained internationally, including in the United States and European countries.
• Holds significant certifications in pediatric hematology and oncology.
• Member of renowned professional bodies like the European Hematology Association.
• Offers online consultations for global patients seeking leukemia chemotherapy expertise.
• Fluent in multiple languages, enhancing communication with diverse patients.

Education

• Ege Faculty of Medicine 1978
• Specialization in Pediatrics 1982
• Subspecialty Pediatric Oncology 2002 (EU Faculty of Medicine)
• Pediatric Hematology and Oncology 2012 (EU Faculty of Medicine)
• Deputy Chief of Clinic 1988 Tepecik EAH
• Clinical Chief 1993 Tepecik EAH
• Associate Professorship 1995
• Professorship  2002
• Ege U. Faculty of Medicine, faculty member 1998 – 2022
• EU Faculty of Medicine Department of Pediatrics 2009-2018
• Member of Tepecik Education Planning and Coordination Board (1993-1998)
• SSI Tepecik Hospital Ethics Committee Chairman (1996-1998)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group Co-Chair" (2002-2006)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group" (2006-2008)
• Turkish Society of Pediatric Hematology - Responsible for Bone Marrow Transplantation "Online" Data Registry System 2007-ongoing.
• Ege University Regenerative Medicine and Cell Commission Chairman, 2011-2021

Institutional Memberships

• Turkish Medical Association İzmir and Kocaeli Branch
• Turkish National Pediatric Association - İzmir
• European Group for Bone Marrow Transplantation (E); Ege University Pediatric Bone Marrow Transplantation Unit was accredited by the European Group for Bone Marrow Transplantation (E) in June 2007.
• Turkish Society of Pediatric Hematology - Board Member for two terms (2005-2009)
• Turkish Society of Hematology - Board Member for two terms (2001/2005)
• Turkish Pediatric Oncology Association
• Bone Marrow Transplantation Foundation (KITVAK) Member of the Board of Trustees

Units he is the founder of                        

1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990) 
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992) 
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998) 
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.  

Transplantation units that he contributed to the establishment of                        

1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019) 
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020) 
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)

Awards

• Thrombotic parameters in stem cell transplant patients, Pediatric Hematology Congress, Trabzon 2003
• CD133 Antigen in Cell: Pediatric Hematology Congress 2005. Research award
• The role of Toll like receptors in febrile neutropenic patients, Best poster award. Turkish Hematology Congress 2008, Çeşme-İzmir
• National pediatric stem cell transplantation activity- Oral presentation second prize, Turkish Hematology Society Cell Transplantation Congress, 2022, Antalya

Publications

Kansoy S. "Bone Marrow and Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir

Kansoy S. in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir

Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5

Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003

Kansoy S. Cell Applications in Bone Marrow and Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005

Kansoy S. Cord Blood as a Cell Source. Cell Special Issue. Turkey Clinics, 2008

Kansoy S. Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017

Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017

Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999.  (1.05 points)

Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)

Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. 

Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016

Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017

Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020

National pediatric stem cell transplant activity, 2020

Childhood stem cell transplantation indications, Turkey Clinics - International book 2020

In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.

Dr. Toluy Özgümüş has graduated from Istanbul University, Cerrahpaşa Faculty of Medicine in 2008 and completed his internal medicine specialty training at Haydarpaşa Numune Training and Research Hospital between 2009 and 2013. He received his Hematology subspecialty training at Marmara University Hematology Department between 2014-2017; He performed his compulsory service at Kars Harakani State Hospital between 2017-2019. He worked at Sancaktepe Şehit Prof. Dr. Ilhan Varak Training and Research Hospital between 2019-2023.

He is experienced in the field of bleeding and coagulation disorders, especially coagulation disorders (thrombophilia), and has dealt with the diagnosis and treatment of more than 1000 patients. Since he worked in the pandemic hospital of the Anatolian side of Istanbul during the pandemic period, he has extensive experience in the hematological findings of Covid-19 infection and the management of Covid-19 infection in hematological diseases. Hundreds of patient experiences are available in the diagnosis of myeloproliferative diseases such as Polycythemia Vera and Essential Thrombocytosis, in their differentiation from blood cell elevations due to other frequently confused causes, and in their treatment. He has experience in the diagnosis and all treatment processes of rare hematological cancers such as multiple myeloma, acute and chronic leukemias, lymphomas and histiocytosis, as well as transplantation.

MEDICAL INTERESTS 

Clotting Disorders (Thrombophilia)

Bleeding Disorders

Myeloproliferative Diseases

Anemias (Anemia)

Acute and Chronic Leukemias

lymphomas